1029 related articles for article (PubMed ID: 25872541)
1. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
3. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
5. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
Promintzer-Schifferl M; Prager G; Anderwald C; Mandl M; Esterbauer H; Shakeri-Leidenmühler S; Pacini G; Stadler M; Bischof MG; Ludvik B; Luger A; Krebs M
Obesity (Silver Spring); 2011 Jul; 19(7):1420-6. PubMed ID: 21494227
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.
Vidal J; Nicolau J; Romero F; Casamitjana R; Momblan D; Conget I; Morínigo R; Lacy AM
J Clin Endocrinol Metab; 2009 Mar; 94(3):884-91. PubMed ID: 19106269
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
[TBL] [Abstract][Full Text] [Related]
9. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
Rubino F; Gagner M; Gentileschi P; Kini S; Fukuyama S; Feng J; Diamond E
Ann Surg; 2004 Aug; 240(2):236-42. PubMed ID: 15273546
[TBL] [Abstract][Full Text] [Related]
10. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
11. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
Meirelles K; Ahmed T; Culnan DM; Lynch CJ; Lang CH; Cooney RN
Ann Surg; 2009 Feb; 249(2):277-85. PubMed ID: 19212182
[TBL] [Abstract][Full Text] [Related]
13. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
14. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
[TBL] [Abstract][Full Text] [Related]
15. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery.
Hansen EN; Tamboli RA; Isbell JM; Saliba J; Dunn JP; Marks-Shulman PA; Abumrad NN
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G795-802. PubMed ID: 21372167
[TBL] [Abstract][Full Text] [Related]
16. Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
Guarino D; Moriconi D; Mari A; Rebelos E; Colligiani D; Baldi S; Anselmino M; Ferrannini E; Nannipieri M
Diabetologia; 2019 Jan; 62(1):178-186. PubMed ID: 30315341
[TBL] [Abstract][Full Text] [Related]
17. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.
Falkén Y; Hellström PM; Holst JJ; Näslund E
J Clin Endocrinol Metab; 2011 Jul; 96(7):2227-35. PubMed ID: 21543426
[TBL] [Abstract][Full Text] [Related]
18. Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery.
Jorsal T; Wewer Albrechtsen NJ; Christensen MM; Mortensen B; Wandall E; Langholz E; Friis S; Worm D; Ørskov C; Støving RK; Andries A; Juhl CB; Sørensen F; Forman JL; Falkenhahn M; Musholt PB; Theis S; Larsen PJ; Holst JJ; Vrang N; Jelsing J; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2019 Dec; 104(12):6403-6416. PubMed ID: 31276156
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Dirksen C; Jørgensen NB; Bojsen-Møller KN; Jacobsen SH; Hansen DL; Worm D; Holst JJ; Madsbad S
Diabetologia; 2012 Jul; 55(7):1890-901. PubMed ID: 22538359
[TBL] [Abstract][Full Text] [Related]
20. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
